Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ikena Oncology Inc
(NQ:
IKNA
)
1.357
+0.057 (+4.42%)
Streaming Delayed Price
Updated: 2:34 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ikena Oncology Inc
< Previous
1
2
3
Next >
The Analyst Landscape: 4 Takes On Ikena Oncology
March 19, 2024
Via
Benzinga
Ikena Oncology: Q4 Earnings Insights
March 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
Via
Benzinga
Ikena Oncology Refocuses on Key Programs: Analysts Maintain Outperform Ratings Amid Strategic Organizational Changes
January 19, 2024
Ikena Oncology optimizes resources for targeted oncology programs IK-930 & IK-595. Clinical updates expected H2 2024. Workforce reduced by 35%. Financially secure with $175M cash. Strategic focus on...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 15, 2023
Via
Benzinga
Ikena Oncology: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
Analyst Ratings for Ikena Oncology
May 16, 2023
Via
Benzinga
Credit Suisse Maintains Outperform Rating for Ikena Oncology: Here's What You Need To Know
March 15, 2023
Via
Benzinga
Ikena Oncology Earnings Perspective: Return On Capital Employed
March 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 24, 2023
Via
Benzinga
Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
November 24, 2023
Shares of Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) surged in pre-market trading after the company announced its foray into the Middle Ea
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 17, 2023
Via
Benzinga
Dow Falls Over 200 Points; Krispy Kreme Reports Downbeat Results
November 09, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Thursday. The Dow traded down 0.71% to 33,871.77 while the NASDAQ fell 0.87% to 13,531.36. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Ikena Oncology's Return On Capital Employed Insights
November 30, 2022
Via
Benzinga
Ikena Oncology: Q3 Earnings Insights
November 07, 2022
Ikena Oncology (NASDAQ:IKNA) reported its Q3 earnings results on Monday, November 7, 2022 at 08:05 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Is Cancer Firm Ikena Oncology Stock Trading Lower Today?
November 09, 2023
Ikena Oncology Inc (NASDAQ: IKNA) shared initial data from twenty-six patients treated in the ongoing dose escalation portion of the
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 09, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 09, 2023
Via
Benzinga
Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings
November 09, 2023
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53....
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Optimism Surrounds Cancer Focused Ikena Oncology, Analyst Initiates With Outperform
September 22, 2023
Ikena Oncology Inc (NASDAQ: IKNA) is garnering attention with its oncology-focused pipeline, and the company's recent developments have raised optimism in the medical community.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 08, 2023
We're starting off the day with a look at all of the biggest pre-market stock movers worth keeping an eye on for Tuesday!
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
September 22, 2023
Via
Benzinga
Ikena Oncology Acquires Pionyr Immunotherapeutics: Analysts See The Deal As Positive Move
August 07, 2023
Ikena Oncology Inc (NASDAQ: IKNA) acquired Pionyr Immunotherapeutics Inc, a privately-held biotechnology company, in
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 27, 2022
Via
Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
December 09, 2022
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
Via
Benzinga
Ikena Oncology Announces New Cancer Program, Shelves Early Asset For Colorectal Cancer
November 28, 2022
Ikena Oncology Inc (NASDAQ: IKNA) nominated a next-generation mitogen-activated protein kinase (MEK)-RAF complex inhibitor, IK-595, as its first development candidate in the RAS pathway.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
October 31, 2022
During Monday's session, 96 stocks hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 26, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 25, 2022
On Tuesday, 120 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.